Drug Type Small molecule drug |
Synonyms BDHK-2009, BT-101 (Bodihekang) |
Target |
Action agonists |
Mechanism GPCR agonists(G-protein coupled receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Phase 1 | China | 18 May 2026 | |
| Crohn Disease | Phase 1 | China | 18 May 2026 | |
| Inflammatory Bowel Diseases | IND Approval | United States | 13 Jan 2026 |





